BridgeMD
Tests treatment safety and results for Post Traumatic Stress Disorder PTSD
Official title Psychosocial Factors and Efficacy of Remote Cognitive Remediation for Post-Traumatic Stress Disorder
ClinicalTrials.gov ID: NCT07309302
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether computer-based brain training can help adults with post-traumatic stress disorder (PTSD). Individuals with PTSD often experience difficulties with memory, attention, concentration, and problem-solving, which can significantly affect their daily lives, work performance, and overall quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Age 18 to 45 years
- Able to speak and read French fluently
- Access to a computer with a camera and a secure Internet connection
- Access to a private space for assessment and intervention sessions
- Available for the complete treatment protocol
You likely can't join if
- History of neurological disorders (stroke, intracranial surgery, aneurysm, epilepsy)
- Moderate to severe traumatic brain injury OR hospitalization due to traumatic brain injury
- Mild traumatic brain injury less than 6 months ago with persistent symptoms
- Psychotic disorders
- Alcohol abuse or substance dependence disorders
- Video game addiction
See the full eligibility criteria
- Age 18 to 45 years
- Able to speak and read French fluently
- Access to a computer with a camera and a secure Internet connection
- Access to a private space for assessment and intervention sessions
- Available for the complete treatment protocol
- Confirmed current PTSD diagnosis using the Structured Clinical Interview for DSM-5 (SCID-5)
- Residing in Canada
- History of neurological disorders (stroke, intracranial surgery, aneurysm, epilepsy)
- Moderate to severe traumatic brain injury OR hospitalization due to traumatic brain injury
- Mild traumatic brain injury less than 6 months ago with persistent symptoms
- Psychotic disorders
- Alcohol abuse or substance dependence disorders
- Video game addiction
- Hospitalization for major depression or suicide risk within the past 3 months
- Regular use of medications that impact neurocognition, including: benzodiazepines (diazepam, lorazepam, alprazolam, Ativan, Xanax, Rivotril)
- Residence outside Canada
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.